Back to News
Market Impact: 0.35

Could December Be the Turning Point for This Beaten-Down Tech Stock?

FIGADBENFLXNVDANDAQ
Artificial IntelligenceTechnology & InnovationAntitrust & CompetitionCompany FundamentalsCorporate EarningsIPOs & SPACsM&A & RestructuringInvestor Sentiment & Positioning
Could December Be the Turning Point for This Beaten-Down Tech Stock?

Figma reported revenue of $752 million in the first nine months of 2025, up 41% year-over-year, but posted a net loss just over $1 billion versus $830 million a year earlier, driven largely by more than $1.1 billion in stock-based compensation (including $976 million in Q3). Free cash flow for the first three quarters was $204 million, yet the shares have tumbled from a $143 intraday peak to around $34 (near the $33 IPO price) and trade at a price-to-sales ratio of ~17, raising concerns about valuation and shareholder dilution. Adobe’s attempted acquisition — blocked by European antitrust scrutiny — underscores Figma’s product strength and market leadership, but absent a clear catalyst or tighter control of compensation-related dilution, the stock’s recovery appears uncertain.

Analysis

Market structure: Figma (FIG) remains the functional market leader in collaborative, AI-enabled UX/UI design which benefits customers (faster cycles) and cloud providers (AWS/GCP) who host instances; direct competitors like Adobe (ADBE) face sticky customer retention but also stand to gain if FIG weakens. The stock’s P/S ~17 implies investor expectation of sustained high-growth margins; that pricing elevates equity volatility and raises the bar for near-term financial performance, while demand for design SaaS remains strong — supply of credible alternatives is limited, preserving pricing power for winners. Risk assessment: Near-term risks include additional shareholder dilution from continued ~$1.1B quarterly-equivalent stock-based comp (SBC) if management accelerates equity grants — a 10–20% effective share count expansion would be highly dilutive. Regulatory/M&A tail risk remains material (Europe blocked ADBE bid previously); over 0–3 months expect trading range tests around $28–36, 3–12 months hinge on Q4 re: SBC trajectory and FCF conversion, >12 months depend on sustained revenue growth (~40% y/y) and margin improvement. Trade implications: Tactical trades should hedge idiosyncratic risk: consider small, protected long exposure to FIG only if purchased below $36 with defined downside (stop $28) and paired hedges; allocate overweight to profitable software (ADBE, MSFT) where P/S multiples are supported by positive free cash flow. Options can monetize elevated IV — use collars or long-dated call spreads to capture asymmetric upside while capping dilution-driven downside. Contrarian angles: Consensus underweights that FIG reported positive free cash flow (~$204M YTD) and that most losses are noncash SBC — if management cuts SBC or shifts to cash comp, adjusted EPS could swing positive and re-rate the stock. Historical parallels (high-growth SaaS post-IPO drawdowns like CRM/SNOW) show multi-quarters of consolidation before rerating; downside is real if share-count growth continues, but upside is underappreciated if dilution is constrained.